Department of Hepatobiliary Surgery, Daping Hospital and the Field Surgery Research Institute, Third Military Medical University, Chongqing, China.
J Surg Res. 2010 Aug;162(2):231-8. doi: 10.1016/j.jss.2009.04.030. Epub 2009 May 19.
Cell migration is a basis for invasion and metastasis of malignant tumors. Receptor tyrosine kinases are recognized as important therapeutic targets in antineoplastic strategies. C-met is a receptor tyrosine kinase highly expressed in human hepatocellular carcinoma (HCC) cell line MHCC97-H. Higher expression of c-met in tumor tissue can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventually, metastasis. To explore the roles of c-met in modulating the motility of cell, we silenced c-met expression in the HCC line MHCC97-H by RNA interference (RNAi).
For transient expression, c-met-siRNA 1,2 recombinant plasmids were transfected into phoenix A cells. The MHCC97-H cells were cultured in Dulbecco's modified Eagles's medium (DMEM) with 10% fetal bovine serum (FBS) to establish MHCC97-H HCC cells stably expressing c-met-siRNA. MHCC97-H cells were treated with the recombinant virus for assay of c-met mRNA and protein, evaluation of growth and invasion of MHCC97-H cells, and identification of hepatitis B virus X (HBX) protein correlation with c-met.
After transfection of c-met-siRNA for 48 h, the expression of c-met decreased markedly in MHCC97-H cells; the most effective site of the siRNA target sequence is at the 537 upstream, far from the transcription start. In addition, the proliferation, motility, and invasive ability of MHCC97-H cells were significantly inhibited. Furthermore, we showed that hepatitis B virus (HBV) X protein (HBX) potentiated the activities of the extracellular signal-regulated kinase 1/2 (ERK1/2) in MHCC97-H cells. Treatment with extracellular signal-regulated kinase (ERK) inhibitor (U0126), but not P38 MAPK inhibitor (SB203580) or phosphatidylinositol 3-kinase (PI3K) inhibitor (wortmannin), markedly suppressed the expression of c-met protein in MHCC97-H cells.
These results indicate that the over-expression of c-met protein plays an important role in the cell invasion of MHCC97-H, and HBX protein may promote the expression of c-met by ERKs pathway.
细胞迁移是恶性肿瘤侵袭和转移的基础。受体酪氨酸激酶被认为是抗肿瘤策略中重要的治疗靶点。C-met 是一种在人肝癌细胞系 MHCC97-H 中高度表达的受体酪氨酸激酶。肿瘤组织中 c-met 的高表达可导致细胞散射、血管生成、增殖、增强细胞迁移、侵袭,最终转移。为了探讨 c-met 在调节细胞运动中的作用,我们通过 RNA 干扰(RNAi)沉默肝癌细胞系 MHCC97-H 中的 c-met 表达。
为了瞬时表达,将 c-met-siRNA1、2 重组质粒转染到 phoenix A 细胞中。MHCC97-H 细胞在含 10%胎牛血清(FBS)的 Dulbecco's 改良 Eagles 培养基(DMEM)中培养,建立稳定表达 c-met-siRNA 的 MHCC97-H HCC 细胞。用重组病毒处理 MHCC97-H 细胞,检测 c-metmRNA 和蛋白表达,评估 MHCC97-H 细胞的生长和侵袭能力,以及鉴定乙型肝炎病毒 X(HBX)蛋白与 c-met 的相关性。
转染 c-met-siRNA 48 小时后,MHCC97-H 细胞中 c-met 的表达明显下降;siRNA 靶序列的最有效部位在 537 上游,远离转录起始点。此外,MHCC97-H 细胞的增殖、迁移和侵袭能力明显受到抑制。此外,我们表明乙型肝炎病毒(HBV)X 蛋白(HBX)增强了 MHCC97-H 细胞中细胞外信号调节激酶 1/2(ERK1/2)的活性。用细胞外信号调节激酶(ERK)抑制剂(U0126)处理,但不用 p38MAPK 抑制剂(SB203580)或磷脂酰肌醇 3-激酶(PI3K)抑制剂(wortmannin)处理,可显著抑制 MHCC97-H 细胞中 c-met 蛋白的表达。
这些结果表明,c-met 蛋白的过表达在 MHCC97-H 细胞的侵袭中起重要作用,HBX 蛋白可能通过 ERKs 通路促进 c-met 的表达。